Login / Signup
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
Send us Feedback
Longs Drug Stores (LDG)
SUMMARY
BULLS
BEARS
DATA CENTRAL
OPERATING METRICS
REVENUE SOURCES
BALANCE SHEET
INCOME STMT
CASH FLOW
Key Metrics for LDG as compared to
Top Competitors
Drug Stores
Acquired
Exclude From Rankings
New York Stock Exchange
Pharma & Healthcare
Retail
All values TTM unless otherwise noted (*)
INDUSTRY METRICS (
See all
)
Comp. Sales Growth
►
0.9%
Number of Stores
►
510
Square Footage
►
7.57M
Sales per sq. ft
►
630
Front Store Sales
►
2.37B
% of Drug Sales Covered by Third Party Insurers
►
95%
Prescriptions Growth
►
1.8%
Square Footage
Front Store Sales
% of Drug Sales Covered by Third Party I...
Comparable Prescription Sales Growth
Number of Stores
Comparable Sales Growth
Sales per Square Foot
Revenue
Net Income
Operating Income
INCOME STATEMENT (
See all
)
Revenue
►
5.43B
EBITDA
►
281M
Net Income
►
108M
Revenue Growth
►
5.6%
Net Income Growth
►
35.7%
Operating Margin
►
3.3%
Net Margin
►
2%
Revenue, Net Income, and Net Margin
Revenue, Gross Profit, and Gross Margin
Operating Income
Ebit
Income Before Taxes
Net Income from Continuing Ops
Interest vs Continuing Income
Interest Coverage
Operating Expenses
SG&A
Amortization & Depreciation
BALANCE SHEET (most recent quarter) (
See all
)
Debt / Equity
►
1.24
Current Ratio
►
1.35
Quick Ratio
►
0.732
Interest Coverage Ratio
►
16.3
Book Value Per Share
►
23.7
Cash Per Share
►
0.746
Loading...
STOCK SUMMARY
No data.
VALUATION
Price to Earnings (P/E)
►
23.9
Price to Book (P/B)
►
3.02
Price to Sales (P/S)
►
0.474
Return on Assets (ROA)
►
6.5%
Return on Equity (ROE)
►
12.6%
EV/EBITDA
►
9.99
Dividend Yield
0.8%
OWNERSHIP
No data.